Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New antibiotic compounds discovered in soil
The new compounds, named malacidins, were found in soil samples collected from across America.

Malacidins found to eliminate MRSA in rats

Researchers in America have found a new family of antibiotics that can kill drug-resistant bacteria.

The antibiotics, called malacidins, have proven successful at killing several infections that are difficult to treat, including MRSA. Researchers say that discovery, published in Nature Microbiology brings fresh hope in the fight against antibiotic resistance.

In the study, researchers collected 1,800 soil samples from sites across America and used a gene sequencing technique to study them. When they found malacidins in many of the samples, they tested them on rats with induced MRSA and it completely eliminated the infection.

Speaking to BBC News, Dr Sean Brady from Rockefeller University said that his team are now working to improve the drug’s effectiveness so that it can be developed into a treatment for humans.

“It is impossible to say when, or even if, an early stage antibiotic discovery like the malacidins will proceed to the clinic,” he said. “It is a long, arduous road from the initial discovery of an antibiotic to a clinically used entity."

Antibiotic resistance is one of the biggest threats to global health, accelerated by the overuse of antibiotics as well as poor infection prevention and control.
According to the World Health Organisation, almost half a million people developed resistance to TB in 2016 and the issue is starting to complicate the fight against HIV and malaria.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.